Professional Documents
Culture Documents
pubs.acs.org/Macromolecules
ABSTRACT: The design and synthesis of an entirely degradable glycopolymer micelle was presented. This design relies on the
utilization of RAFT-controlled radical ring-opening polymerization (rROP) technique to afford multiple insertions of cleavable
ester linkages onto the backbone of the corona. RAFT polymerization using a macroRAFT agent based on poly(ε-caprolactone)
PCL was employed to control the polymerization of well-defined statistical glycopolymers of 1-O-acryloyl-2,3:4,5-di-O-
isopropylidene-β-D-fructopyranose (1-O-AiPrFru) and 5,6-benzo-2-methylene-1,3-dioxepane (BMDO) monomer. Three block
copolymers were synthesized to generate poly(ε-caprolactone)-b-poly[(1-O-acryloyl-2,3:4,5-di-O-isopropylidene-β-D-fructopyr-
anose)-co-(5,6-benzo-2-methylene-1,3-dioxepane)] (PCL-b-P[(1-O-AiPrFru)-co-(BMDO)]) with varying block lengths. Self-
assembly of the deprotected block copolymers generated nonspherical egg shaped micelles, where the shorter chains PCL106-b-
P[(1-O-AFru)69-co-(BMDO)9] underwent self-assembly forming micelles with the hydrodynamic diameter (DH) of 106 nm. The
biodegradation of these micelles were investigated via enzymatic degradation by Lipase Pseudomonas sp., indicating entirely
degradable architectures, which are no longer visible via dynamic light scattering (DLS). SEC further confirmed the appearance
of fragmented glycopolymeric units. In vitro cell proliferation assay of the micelles and their degradation products revealed no
toxicity against healthy human fibroblast HS27 and breast cancer MDA-MB-231 cell lines. The polymer concentration range
tested was up to 0.20 mg·mL−1 with the cell viabilities of ≥95%.
■ INTRODUCTION
Glycopolymers as synthetic materials bearing natural carbohy-
extended through a collective binding effect, also known as
cluster glycoside ef fect caused by multivalent ligands binding with
drate-based derivatives have been long known and explored to lectins.3,4 Carbohydrate-coated nanoparticles accommodate
deliver therapeutics in a targeted fashion. The structure of extended advantages by not only promoting cell recognition
glycopolymers that mimic natural carbohydrates in biological as naturally occurring polysaccharide derivatives, but also in the
systems offer myriad advantages. Carbohydrates are involved in ability to stimulate active targeting with carbohydrate binding
many of the essential biological processes related to proteins and transporters. A plethora of carbohydrate decorated
reproduction, inflammation, signal transmission, and biomo- nanoparticles have been demonstrated to promote selective and
lecular recognition events such as cell differentiation and active targeting.5−8 Despite significant advances from synthetic
infection. Building upon this foundation, carbohydrate-directed and conceptual viewpoints followed by the promising outcomes
targeting has been used as a classic approach in promoting of carbohydrate-based nanocarriers, the persisting issue of
active targeting by utilizing the carbohydrate ligands that are nondegradability of the glycopolymers may cause unwanted
recognized by the carbohydrate-binding proteins (receptors) immune responses and toxicity, eventually preventing their
on cell surfaces known as lectins.1 This activity induces cell− translation toward in vivo application. The biomaterials
cell interactions, mediating an increase in cellular uptake via intended for biomedical applications require definite bio-
receptor-endocytosis.2 The prominent feature of cell recog- compatibility and biodegradability.9 Previous studies reported
nition mediated by carbohydrate-based therapeutics draws
major attention as a potential agent for targeted drug delivery. Received: February 4, 2016
Although a single interaction is considerably weak, the Revised: April 25, 2016
advantages of using glycopolymers as drug carriers can be Published: June 2, 2016
Cytotoxicity Test and SRB Assay. The cytotoxicity of glycopolymer 11.8 Hz), 4.38 (dd, 1H, 5, 3J5,6 = 2.6 Hz), 4.27 (m, 1H, 7), 4.16 (dd,
micelles and their degradation products were determined by a standard 1H, 8′, 2J8′,8 = 11.8 Hz), 3.87 (m, 1H, 4), 1.57, 1.51, 1.41, 1.37 (4s,
sulforhodamine B colorimetric proliferation assay (SRB assay). After 12H, 4 × 9) (Figure S1, Supporting Information).
incubation with the enzyme, the degradation products were heated to Synthesis of 5,6-Benzo-2-(bromomethyl)-1,3-dioxepane.34 A 10.0
85 °C for 15 min in order to deactivate the enzyme. MDA-MB-231 g sample of o-benzene dimethanol (72.4 mmol, 1.0 equiv) and 12.3 g
(human breast carcinoma) and HS27 (human fibroblast non- bromodimethyl acetaldehyde (72.4 mmol, 1.0 equiv) were mixed in a
cancerous) cell lines were seeded at the corresponding density of predried nitrogen flask equipped with a Claisen bridge under argon
4,000 cells per well in 96-well microtiter plates followed by the atmosphere. Then, 0.16 g of p-toluenesulfonic acid (0.93 mmol) was
addition 100 μL of RPMI-1640 culture medium per well and incubated added, and the mixture was heated to 120 °C for 18 h. Following, the
at 37 °C in a 5% CO2 for 24 h. The specimens were sterilized by UV product obtained was of dry solid and was left to cool down. The
irradiation for 20 min before serially diluting (sequential 2 × dilution) crude solid was dissolved in 60.0 mL of CHCl3 and washed with 30.0
with sterile water. For the cytotoxicity assay, the medium in the cell mL of saturated NaHCO3− solution and water. The excess water was
culture plate was discarded, and 100 μL of fresh 2 × concentrated removed by drying over MgSO4. The solution was then filtered and
RPMI-1640 medium was added to each well of the plate. The micelles solvent removed by evaporation under reduced pressure. The product
and degradation products were added correspondingly into the plates obtained was recrystallized from 0.1 L cyclohexane to yield 14.5 g
at 100 μL per well. Sterile water was added to the nontreated cells as a (82%). 1H NMR (300.17 MHz, CDCl3), δ (ppm): 7.16−7.24 (m,
control. The cells were incubated with the micelles for 48 h, and the 4H), 5.12 (t, 1H, 3J = 5.12 Hz), 4.93 (d, 4H, 3J = 1.8 Hz), 3.46−3.44
cell viability was determined using SRB assay. The incubation with (d, 2H, 3J = 5.2 Hz).
micelles was terminated by the addition of cold trichloroacetic acid Synthesis of 5,6-Benzo-2-methylene-1,3-dioxepane (BMDO).34
(TCA) (10% w/v) for 30 min at 4 °C. After a complete washing with First, 14.47 g of 5,6-benzo-2-(bromomethyl)-1,3-dioxepane (59.54
distilled water (5 times), the TCA-fixed cells were stained with 100 μL mmol, 1 equiv) was dissolved in 100.0 mL of tert-butanol in a predried
of 0.4% w/v sulforhodamine B (SRB) solution in 1% acetic acid (w/v) round-bottom Schlenk flask under nitrogen. Then, 6.83 g of potassium
for 15 min. After staining, unbound dye was removed by washing with tert-butylate (60.86 mmol, 1.0 equiv) was added and the solution was
1% acetic acid for five times, and plates were air-dried. Finally, the SRB heated to reflux for 18 h. The reaction mixture was left for cooling
was solubilized with 200 μL of 10 mM unbuffered Tris base to dissolve before the addition of 100.0 mL of Et2O to establish separation and
bounded dye, and the optical density was determined by using a filtered through vacuum filtration. The solvents were then evaporated
multiwell scanning spectrophotometer at the wavelength of 490 nm. with the resulting oil distilled at reduced pressure (2.6 mbar) at 107 °C
Dose−response curves were plotted accordingly where the values were to yield colorless liquid which solidified to form white crystal solids on
expressed as percentage of control (nontreated cells were used as standing. 1H NMR (400.13 MHz, toluene-d8), δ (ppm): 3.92 (s, 2H,
controls). The optical density was used to calculate cell viability. B1), 4.76 (s, 4H, B2) 6.57−6.59 (m, 2H, Ar), 6.91−6.93 (m, 2H, Ar)
(Figure S2, Supporting Information).
OD490,sample − OD490,blank Synthesis of Poly(ε-caprolactone) Macro-RAFT Agent.35 Poly(ε-
cell viability (%) = × 100
OD490,control − OD490,blank caprolactone) macro-RAFT agent was synthesized by adopting a
procedure previously conducted by Bourissou et al. with slight
Synthesis. Protection of D-Fructose. Synthesis of 2,3:4,5-Di-O- modifications.
isopropylidene-β-D-fructopyranose.36 Dry and finely powdered D- The monomer ε-caprolactone was predistilled prior to reaction and
fructose (5.0 g, 27.75 mmol) was added to a cooled mixture of anhydrous toluene was obtained from a MBraun solvent purification
concentrated sulfuric acid (5.0 mL) and acetone (100.0 mL) in an system packed with aluminum oxide reactor filter column. 0.933 g of ε-
Erlenmeyer flask. The suspended mixture was left stirring on a caprolactone (8.18 mmol, 80.0 equiv) was added into a Schlenk flask
magnetic stirring plate at room temperature until all the sugar had equipped with a magnetic stirrer bar that was previously flame-dried
dissolved. The solution was left sitting at room temperature for an under vacuum. Benzyl 2-hydroxyethyl carbonotrithioate (BHCT)37
additional 80 min before cooling with ice. Following, an ice-cold RAFT agent (0.102 mmol, 1 equiv) as the initiator and anhydrous
solution of 2.75 M NaOH (15.3 g, 1.1 equiv) was added gradually toluene were then added to the flask under inert atmosphere and
upon stirring. The crude product was a crystalline solid, isolated via mixed. The solvent was then removed under reduced pressure via
recrystallization by dissolving in boiling ether, cooling and adding rotary evaporator and was repeated for three times until all the solvent
hexane to give the final product of rosette of needles. 1H NMR was removed. Subsequently, methanesulfonic acid (0.307 mmol, 3
(300.17 MHz, DMSO-d6) δ (ppm): 5.06 (t, 1H, J = 5.8 Hz), 4.56 (dd, equiv) was added to the flask under N2 flow to catalyze the reaction,
1H, H-4, 3J4,3 = 2.5 Hz), 4.27 (d, 1H, H-3, 3J3,4 = 2.5 Hz), 4.21 (dd, followed by the addition of anhydrous toluene (0.5 M). The reaction
1H, H-5), 3.73 (dd, 1H, H-2, 2J2,2′ = 4.9 Hz), 3.53 (dd, 1H, H-2′, 2J2′,2 flask was then immersed into a preheated oil bath at 30 °C and left to
= 4.5 Hz), 3.39 (m, 2H, H-6), 1.44, 1.34, 1.27 (4s, 12H, 4 × CH3). react under N2 atmosphere for 4 h. Finally, the reaction was quenched
Glycosylation of Protected D-Fructose Derivative. Synthesis of 1- by the addition of N,N-diisopropylethylamine in excess.
O-Acryloyl-2,3:4,5-di-O-isopropylidene-β-D-fructopyranose (1-O- Synthesis of Poly[(1-O-AiPrFru)-co-(BMDO)] via RAFT Polymer-
AiPrFru). First, 3.0 g (11.53 mmol) of 2,3:4,5-di-O-isopropylidene-β- ization. Below is provided a typical procedure for the statistical radical
D-fructopyranose and 3.23 mL of triethylamine (Et3N, 23.05 mmol) ring-opening RAFT polymerization of 1-O-acryloyl-2,3:4,5-di-O-
were added to a three-neck round-bottom flask equipped with a isopropylidene-β-D-fructopyranose (1-O-AiPrFru) monomer with
magnetic stirrer bar and dissolved in anhydrous dichloromethane 5,6-benzo-2-methylene-1,3-dioxepane (BMDO) monomer. This gen-
(270.0 mL) under argon atmosphere and cooled in an ice bath. eral procedure was employed for a series of statistical glycopolymer
Acryloyl chloride (1.44 mL, 5.85 mmol) dissolved in 90.0 mL of dry syntheses by varying the monomer feed ratios.
DCM was added dropwise with stirring under argon flow. The 1-O-Acryloyl-2,3:4,5-di-O-isopropylidene-β-D-fructopyranose (1-O-
solution was allowed to warm to room temperature overnight. The AiPrFru) (0.307 g, 0.976 mmol), benzyl 2-hydroxyethyl carbon-
reaction mixture was poured into ice-cold water and extracted three otrithioate RAFT agent (BHCT, 0.057 g, 0.00610 mmol), and 1,1′-
times with DCM (270.0 mL) and dried over Na2SO4. The solvent was azobis(cyclohexanocarbonitrile) (VAZO88, 0.3 × 10−3 g, 1.22 × 10−3
removed by rotovapping to give a sticky orange residue, which was mmol) were added into a Schlenk flask that was previously flame-
purified by silica gel column chromatography by using a mixture of dried, equipped with a magnetic stirrer bar under N2 flow. The flask
ethyl acetate:n-hexane = 1:2 v/v % as the eluent to obtain maximum was transferred into the glovebox and 5,6-benzo-2-methylene-1,3-
separation. The product fractions were combined and solvent removed dioxepane (BMDO, 0.0396 g, 0.244 mmol) was added, followed by
under reduced pressure to yield pure sticky clear gel glycomonomer. the addition of 0.60 mL of anhydrous anisole to give [1-O-AiPrFru]0:
1
H NMR (300.17 MHz, CDCl3), δ (ppm): 6.51 (dd, 1H, 1, 2J1, 1′ = 1.4 [BMDO]0:[BHCT]:[VAZO88] = 80:20:1.0:0.1 with the total
Hz), 6.19 (dd, 1H, 3, 3J3, 1,1′ = 10.4 Hz), 5.88 (dd, 1H, 2, 2J1′,1 = 1.4 concentration of 2.0 M. The flask was then sealed with a glass
Hz), 4.64 (dd, 1H, 6, J = 7.9, 3J6,5 = 2.6 Hz), 4.53 (dd, 1H, 8, 2J8,8′ = stopper and deoxygenated by 3 cycles of freeze−pump−thaw until all
the dissolved gas was removed. The flask was then immersed in an oil monitoring of RAFT statistical copolymerization kinetics via NMR
bath preheated to 90 °C and left to react for 24 h. The polymerization spectroscopy.
was stopped by immersing the tube into an ice bath and introduced to The statistical copolymerization was performed under a similar
air. The crude sample was diluted in CHCl3 and precipitated for 3 procedure as described previously, unless for the substitution of
times into chilled methanol and isolated by centrifugation before anhydrous anisole as the polymerization solvent to toluene-d8. Upon
drying in vacuo to obtain pure statistical glycopolymer. the addition of BMDO monomer into the reaction mixture in the
Real-Time 1H and 1H−13C HSQC NMR Monitoring of RAFT glovebox, the reaction mixture was transferred into a J-Young NMR
Statistical Copolymerization Kinetics. All the kinetic experiments tube and sealed under N2 and taken out of the glovebox. The solution
including 1H and 1H−13C HSQC NMR spectra respectively were was deoxygenated via 3 cycles of freeze−pump−thaw. The NMR tube
recorded on a Bruker Avance III 400 MHz spectrometer equipped was then subjected to in situ online NMR kinetics experiment carried
with an ultrashielded magnet and BBFO probe. Tetramethylsilane out on a Bruker Avance III 400 MHz spectrometer equipped with an
(TMS) was used as internal standard. 1H NMR data were acquired ultrashielded magnet and BBFO probe. Tetramethylsilane (TMS) was
with 8 scans with a relaxation delay of 10 s. Meanwhile, 2D NMR data used as internal standard. The magnet was preheated to 90 °C before
were acquired with 1 scan and 2048 points in t2, and the number of the tube was injected and the reaction started. Polymerization kinetics
increments for t1 was 128. Below is a typical procedure for the online were monitored and quantified by comparing the integral ratio of
Figure 1. 1H NMR spectra (400.13 MHz, toluene-d8) of the online in situ kinetics experiment of RAFT statistical copolymerization of 1-O-AiPrFru
and BMDO monomers with [1-O-AiPrFru]0:[BMDO]0:[CTA]:[VAZO88] = 65:35:1:0.1 at 90 °C for 15.4 h.
polymeric to monomeric peaks accordingly with respect to time. The before transferring it into the glovebox. 5,6-Benzo-2-methylene-1,3-
polymerization was quenched by immersing the tube into an ice bath dioxepane (BMDO, 0.0396 g, 0.244 mmol) was added into the flask
and exposing it to air. The crude sample was purified and upon the addition of 0.600 mL of anhydrous Anisole to give a[1-O-
glycopolymer isolated according to the similar procedure described AiPrFru]0:[BMDO]0 [macroRAFT]:[VAZO88] = 80:20:1.0:0.1 and
previously. [M] = 2.0 M. The tube was sealed with a glass stopper and
Synthesis of Block Copolymer Poly(ε-caprolactone)-block-poly- deoxygenated by 3 cycles of freeze−pump−thaw until all the dissolved
[(1-O-AiPrFru)-co-(BMDO)]. 1-O-Acryloyl-2,3:4,5-di-O-isopropylidene- gas was removed. The flask was then immersed in an oil bath
β-D-fructopyranose (1-O-AiPrFru) (0.307 g, 0.976 mmol), poly(ε- preheated to 90 °C for 24 h. Following, the flask was immersed into an
caprolactone) (PCL)106, MnTheo = 12 084 Da (0.057 g, 0.00610 mmol) ice bath and exposed to air in order to stop the polymerization. The
as macro-RAFT agent, and 1,1′-azobis(cyclohexanocarbonitrile) crude sample was precipitated for 3 times into chilled methanol and
(VAZO88, 0.3 × 10−3 g, 1.22 × 10−3 mmol) were added into a isolated by centrifugation before drying in vacuo to obtain pure block
previously flame-dried Schlenk flask equipped with a magnetic stirrer copolymer subjected toward characterization.
bar. The Schlenk flask used was previously evacuated and refilled with Removal of Isopropylidene Protecting Groups. The removal of the
N2 gas for 3 cycles on the Schlenk line upon drying by flaming with a isopropylidene protecting groups from poly(ε-caprolactone)-b-poly-
carbon monoxide flame torch. Following, the flask was evacuated [(1-O-acryloyl-2,3:4,5-di-O-isopropylidene-β-D-fructopyranose)-co-
Figure 2. Plot of (a) monomer conversion and (b) total monomer conversion vs time for copolymerization of 1-O-AiPrFru and BMDO at different
feed ratios [1-O-AiPrFru]0:[BMDO]0 = 80:20 (◆) and 65:35 (○) monitored via in situ NMR experiments for 19 h at 90 °C. (c) SEC traces
(DMAC eluent, cal. to PMMA standard) of a series of statistical glycopolymers synthesized via RAFT polymerization with varying comonomer feed
ratios, i.e. [1-O-AiPrFru]0:[BMDO]0 = [100]:[0] (black line); [80]:[20] (blue line); [75]:[25] (green line); [65]:[35] (red line).
Table 1. Synthesis of Statistical Glycopolymers Based on 1-O-AiPrFru and BMDO Monomers via RAFT Polymerization and the
Solubility of the Resulting Copolymers at a Monomer Concentration of 1.0 mg·mL−1 a
monomer feed SECb solubility
entry [1-O-AiPrFru]c
[BMDO] d
Mn (Da) Đ water DMSO phosphate buffer
1 100 0 9700 1.21 yes yes yes
2 80 20 6800 1.14 yes yes yes
3 75 25 10 300 1.35 yes yes yes
4 65 35 8000 1.14 yes yes yes
a
Each polymerization was carried out at 90 °C for 24 h, in the presence of VAZO88 as the initiator and BHCT CTA; [M]0:[BHCT]:[VAZO88] =
[100]:[1]:[0.1]. bSEC analyses were obtained by using DMAc as the mobile phase, calibrated to PMMA standard. cConversion is >90%;
d
Conversion is ∼40%
Figure 3. TEM images of (a) the self-assembly of statistical glycopolymers P(1-O-AFru)50-co-P(BMDO)3 forming nanoparticles with the mean
diameter of 85 nm. (b) Higher concentration solution formed aggregation at 1.0 mg·mL−1.
statistical copolymerization with the monomer feed ratio of [1- susceptible to side reactions. A number of different studies in
O-AiPrFru]0:[BMDO]0 = [65]:[35]. Each polymerization was the literature have also reported similar findings supporting this
conducted under dry and inert environment in the presence of outcome where reversible chain-transfer catalyzed polymer-
1,1′-azobis(cyclohexanecarbonitrile) (VAZO88) as the initiator ization (RTCP) techniques19,20 and free radical polymer-
and benzyl 2-hydroxyethyl carbonotrithioate (BHCT) as the ization39,40 were employed. Four polymers with BMDO feed
chain transfer agent (CTA). A detailed study of the ratio from f BMDO = 0 to 35 mol % were isolated after 24 h and
copolymerization kinetics was performed and monitored via purified. The resulting glycopolymers exhibit narrow disper-
in situ NMR experiment where toluene-d8 was used as the sities (Đ) within 1.14−1.35 (Table 1). It is important to note
reaction solvent and to lock the NMR signal. NMR spectra that the presence of traces of water can result in the hydrolysis
were recorded for 19 h via 1H and 2D 1H−13C HSQC NMR of BMDO monomer, generating byproducts with the structure
spectroscopy. A gradual decrease in both the monomer depicted in Figure S7(a), Supporting Information. Therefore,
concentrations is evident from the loss of intensity of the the incorporation of ester units on copolymer backbone was
characteristic peaks of the monomers, i.e., the acrylate peaks further confirmed by the integration of the 2 protons peak
(CH2CH) of 1-O-AiPrFru monomer labeled “F1”, “F2”, and adjacent to the ester functional group at δ = 5.06−5.4 ppm
“F3” at δ = 6.3−5.3 ppm, followed by the vinyl peak of BMDO (“4”).
monomer labeled “B1” (CH2) at δ = 3.7 ppm (Figure The resulting polymers were subsequently deprotected, and
1(bottom)). The radical ring-opening polymerization of the removal of the isopropylidene groups was confirmed by
BMDO monomer was clearly observed from the decrease of NMR. The resulting copolymers were tested in regards to their
the vinyl bond signal (CH2) at δ = 3.7 ppm (labeled “B1”), water-solubility as the hydrophobic BMDO may lower the
followed by the appearance of the broad polymer peak in the hydrophilicity of the glycopolymer. The solubility of these
range of δ = 5.06−5.4 ppm labeled “4” (Figure 1 (top)) in the glycopolymers was therefore tested using three different polar
spectra. The conversion of BMDO monomer throughout the solvents, such as pure water, dimethyl sulfoxide (DMSO) and
polymerization was monitored and quantified based on the phosphate buffer solution, depicting good solubility with up to
integration of the vinyl bond (“B1”). 35 mol % of BMDO in the monomer feed (Table 1, entry 4).
The conversion for both monomers over 19 h was recorded Despite the apparent water-solubility, the hydrophobic BMDO
for feed ratios of f BMDO = 20 mol % and f BMDO = 35 mol % clearly introduced amphiphilicity to the polymer as it is evident
(Figure 2a), respectively, revealing the significantly slower from the TEM images as shown in Figure 3, parts a and b, using
consumption of BMDO. The amount of BMDO in the initial poly[(1-O-AFru)50-co-(BMDO)3] (Table 1, entry 3). This
feed did not show a major impact on the total monomer behavior suggested that the glycopolymers formed reorganized
conversion and polymerization rate (Figure 2b) with 1-O- and underwent aggregation to form dense hydrophobic
AiPrFru reaching almost complete conversion while the domains surrounded by a corona of swollen loops formed by
conversion of BMDO levels off at 40%. It seems that the the hydrophilic parts of the copolymer.
increasing concentration of BMDO increases the rate of Synthesis of Block Copolymers and Self-Assembly.
polymerization. However, this might solely be the results of Although the statistical copolymers were already capable of
various factors such as impurities as the BMDO monomer is nanoparticle formation, the combination with a hydrophobic
4142 DOI: 10.1021/acs.macromol.6b00266
Macromolecules 2016, 49, 4136−4146
Macromolecules Article
polymer block that will enable the self-assembly into core−shell these block copolymers lie within 1.18−1.40, exhibiting a good
structures will ensure potentially high drug loading capacity for control over molecular weight distribution by RAFT polymer-
a hydrophobic drug. Following the statistical copolymerization ization. The higher dispersity value block copolymers PCL106-b-
of 1-O-AiPrFru and BMDO monomer, which displayed good P[(1-O-AiPrFru)69-co-(BMDO)9] (Đ = 1.29) indicated the
control under RAFT conditions, a series of amphiphilic well- presence of a minor branching on the backbone due to
defined PCLx-b-P[(1-O-AiPrFru)y-co-(BMDO)z] block copoly- backbiting leading to the formation of side chains.18 This is also
mers were synthesized. The block copolymers with varying evident from the SEC chromatogram displaying monomodal
chain lengths and comonomers compositions were synthesized molecular weight distribution with a higher molecular weight
via chain extension of PCL macro-RAFT agent with two shoulder depicted as dashed line in Figure 5. The deprotection
different number of repeating units (DPn = 72, MnObs. = 8.50 of block copolymers was performed under acidic environment
kDa, Mn,SEC = 5.0 kDa, Đ = 1.48 and DPn = 106, MnObs. = 12.3 in order to remove the isopropylidene protecting groups prior
kDa, Mn,SEC = 17.0 kDa, Đ = 1.12). PCL was synthesized via to self-assembly forming micelles. The elimination of the
organo-catalyzed ring-opening polymerization of ε-caprolac- protecting groups is noticeably marked by the disappearance of
tone, initiated by alcohol functionalized BHCT RAFT agent in the isopropylidene peaks between δ = 1.2−1.6 ppm,
the presence of methanesulfonic acid as the catalyst. The block accompanied by a change in solubility. It should be noted
copolymerization was carried out under similar condition to the here that SEC analysis of the deprotected block copolymers is
previously conducted statistical copolymerization of 1-O- not available due to the disparate solubility of both blocks.
AiPrFru and BMDO monomer with the substitution of NMR analysis however suggests that the BMDO esters were
BHCT RAFT agent to PCL macro-RAFT agent. The not cleaved during hydrolysis in acidic conditions, indicated by
incorporation of BMDO comonomer in the feed ( f BMDO) the presence of the peak at δ = 5.0−5.3 ppm which belongs to
varied between 0 and 20 mol %. the 2 protons adjacent to the ester bond corresponding to the
The molecular structure and 1H NMR of a representative aliphatic polyester structure.
block copolymer sample is shown in Figure 4 before and after It is widely established that well-defined amphiphilic block
copolymers are capable of undergoing self-assembly forming
nanoparticles with various morphologies in aqueous solution as
a consequence to the unfavorable interaction between the
hydrophobic segments and the surrounding aqueous environ-
ment. According to the protocol introduced by Eisenberg and
co-workers, the micelles were prepared by initially dissolving
the block copolymer in a suitable organic solvent. Micellization
was induced with the dropwise addition of deionized water.41,42
The sizes and morphologies of micelles prepared from different
block copolymers (Table 2) were determined by transmission
electron microscopy (TEM), indicating ellipsoidal (egg) shaped
micelles for M-1 with an average size of 60 × 143 nm (W × H)
(Figure 6a). Meanwhile, the micelles formed by M-2 provided a
mixture of both ellipsoidal and spherical micelles with an
average width and height of 69 and 125 nm (W × H) (Figure
6b) consecutively. In comparison, M-3 micelles are greater in
size at 86 × 232 nm as a result of the longer hydrophilic
segment and were observed to be unstable in aqueous solution,
which is expected for micelles with such length ratio (Figure S8,
Supporting Information). The high crystallinity of PCL as the
core-forming block led to the formation of egg-shaped micelles
with a clear core−shell structure due to crystallization.43−46
Dynamic light scattering (DLS) provides a supporting evidence
Figure 4. 1H NMR spectra (300.17 MHz) of (a) poly(ε- of the hydrodynamic diameter (DH) of the micelles in aqueous
caprolactone)-b-poly[(1-O-AiPrFru)-co-(BMDO)] (in CDCl3) and solution to be approximately 134 nm (by intensity) for M-1,
(b) poly(ε-caprolactone)-b-poly[(1-O-AFru)-co-(5,6-benzo-2-methyl- 106 nm for M-2, and 269 nm for M-3. A first indication of the
ene-1,3-dioxepane)] (in DMSO-d6) after deprotection of the sugar
stability of M-2 micelles was depicted by the enduring
moieties showing complete disappearance of the isopropylidene
protecting groups. hydrodynamic diameter as recorded by DLS after isolation
and redissolving in aqueous solution. The sizes observed by
TEM and DLS are in similar orders of magnitude, but they
deprotection of the sugar moieties. The incorporation of ester cannot be directly compared due to the nonspherical shape.
backbone obtained from a successful radical ring-opening Enzymatic Degradation. Randomly distributed ester
polymerization is marked by the appearance of the peak at δ = bonds were incorporated into the shell-forming block of the
5.0−5.3 ppm, a characteristic peak of the two protons adjacent micelles to induce biodegradability. Intracellular lysosomal
to the ester bond (“4”) on the glycopolymer backbone. A enzymes are known to promote hydrolysis toward hydrolyti-
summary of the physical characterization and size measure- cally labile polymeric backbones within the cells.47,48 Numerous
ments is presented in Table 2. SEC (Figure 5) depicts a clear studies have been carried out to demonstrate and mimic the
shift in molecular weight of the PCL macro-RAFT agent to the biodegradation of these polymers, such as polyesters,
higher molecular weight region, indicating successful chain polyanhydrides,49 polypeptides50 etc. via in vitro and in vivo
extension forming block copolymers. The dispersities (Đ) of pathways. Bearing this in mind, we designed our micelles to be
4143 DOI: 10.1021/acs.macromol.6b00266
Macromolecules 2016, 49, 4136−4146
Macromolecules Article
Table 2. Characterization and Analysis of a Series of Block Copolymers of Three Different Chain Lengths PCLx-b-P[(1-O-
AiPrFru)y-co-(BMDO)z] and the Micelle Sizes and Morphologies Formed by Self-Assembly in DMSO Followed by the
Dropwise Addition of Water
NMRa SECb DLSc TEMc
sample block copolymer MnTheo. (Da) Mn (Da) Đ DHd (nm) PdI sizee (nm) morph.
M-1 PCL72-b-P(1-O-AiPrFru)88 31 700 16 400 1.18 134 0.178 60 × 143 ellipsoidal
M-2 PCL106-b-P[(1-O-AiPrFru)69-co-(BMDO)9] 32 400 16 000 1.29 106 0.085 69 × 125 ellipsoidal and spherical
M-3 PCL106-b-P[(1-O-AiPrFru)150-co-(BMDO)24] 60 500 14 000 1.38 269 0.160 86 × 232 ellipsoidal
a
Theoretical molecular weight based on monomer conversion (1H NMR, CDCl3). bSEC analyses were obtained by using THF as the mobile phase
(calibrated with PMMA standards). cThe micelles were formed after deprotection of the isopropylidene protecting groups forming PCLx-b-P[(1-O-
AFru)y-co-(BMDO)z]. dThe hydrodynamic volume (DH) of the nanoparticles as measured by dynamic light scattering (DLS) measurement based on
intensity mean. eTEM data obtained by measuring the sizes of negatively stained nanoparticles recorded as width × height.
Figure 6. TEM images of (a) PCL72-b-P(1-O-AFru)88 block copolymers forming ellipsoidal shaped micelles and of (c) PCL106-b-P[(1-O-AFru)69-co-
(BMDO)9] block copolymers forming a mixture of spherical and ellipsoidal shaped micelles. DLS histogram of (b) PCL72-b-P(1-O-AFru)88 and (d)
PCL106-b-P[(1-O-AFru)69-co-(BMDO)9] block copolymers micelles indicating the hydrodynamic volume (DH) of micelles in aqueous solution based
on intensity mean.
Figure 7. Enzymatic degradation of the micelles of (a) PCL106-b-P[(1-O-AFru)69-co-(BMDO)9] and (b) PCL72-b-P(1-O-AFru)88 block copolymers
in number-based hydrodynamic diameter (DH) of the micelles recorded via in situ DLS measurement during enzymatic degradation. Blank micelle:
Micelle solution before enzyme addition; t0: after addition of enzyme.
Figure 8. Cytotoxicity studies of glycopolymeric micelles M-1 and M-2 and their degradation products after incubation with lipase Pseudomonas sp.
(M-1 degraded and M-2 degraded) using SRB assays against (a) HS27 and (b) MDA-MB-231 cell lines at different concentrations after 48 h
incubation period (values expressed as the percentage of nontreated cells as controls).
■ CONCLUSION
By utilizing RAFT to control radical ring-opening polymer-
biodegradable drug delivery platform that can be tailored to
achieve a high degree of main chain scission by enzymatic
attack in a short period of time. The feasibility of the RAFT
ization, we have demonstrated the synthesis of a completely process to control the polymerization was depicted from the
4145 DOI: 10.1021/acs.macromol.6b00266
Macromolecules 2016, 49, 4136−4146
Macromolecules Article
formation of well-defined and controlled statistical glycopol- (19) Huang, J.; Gil, R.; Matyjaszewski, K. Polymer 2005, 46, 11698.
ymers and block copolymers as proven by NMR spectroscopy (20) Siegwart, D. J.; Bencherif, S. A.; Srinivasan, A.; Hollinger, J. O.;
and SEC with narrow molecular weight distributions. The ratio Matyjaszewski, K. J. Biomed. Mater. Res., Part A 2008, 87A, 345.
of BMDO incorporation was able to be finely tuned to attain (21) Yuan, J.-Y.; Pan, C.-Y.; Tang, B. Z. Macromolecules 2001, 34,
211.
different degrees of cleavable ester bonds while maintaining the (22) Smith, Q.; Huang, J.; Matyjaszewski, K.; Loo, Y.-L. Macro-
amphiphilic nature of the final block copolymers and integrity molecules 2005, 38, 5581.
of the micelles product of self-assembly. We have also (23) Lutz, J.-F.; Andrieu, J.; Ü zgün, S.; Rudolph, C.; Agarwal, S.
confirmed the biocompatibility of the materials and degradation Macromolecules 2007, 40, 8540.
products to be nontoxic via in vitro cell proliferation assay (24) Yuan, J.-Y.; Pan, C.-Y. Eur. Polym. J. 2002, 38, 1565.
against healthy human fibroblast (HS27) and breast cancer (25) Kobben, S.; Ethirajan, A.; Junkers, T. J. Polym. Sci., Part A:
(MDA-MB-231) cell lines. Polym. Chem. 2014, 52, 1633.
■
*
ASSOCIATED CONTENT
S Supporting Information
(26) He, T.; Zou, Y.-F.; Pan, C.-Y. Polym. J. 2002, 34, 138.
(27) Paulusse, J. M.; Amir, R. J.; Evans, R. A.; Hawker, C. J. J. Am.
Chem. Soc. 2009, 131, 9805.
(28) d’Ayala, G. G.; Malinconico, M.; Laurienzo, P.; Tardy, A.;
The Supporting Information is available free of charge on the Guillaneuf, Y.; Lansalot, M.; D’Agosto, F.; Charleux, B. J. Polym. Sci.,
ACS Publications website at DOI: 10.1021/acs.macro- Part A: Polym. Chem. 2014, 52, 104.
mol.6b00266. (29) Bell, C. A.; Hedir, G. G.; O’Reilly, R. K.; Dove, A. P. Polym.
NMR spectra, TEM image of the micelles and DLS and Chem. 2015, 6, 7447.
SEC of the degradation profile (PDF) (30) Hedir, G. G.; Bell, C. A.; O’Reilly, R. K.; Dove, A. P.
■
Biomacromolecules 2015, 16, 2049.
(31) Gregory, A.; Stenzel, M. H. Prog. Polym. Sci. 2012, 37, 38.
AUTHOR INFORMATION (32) Decker, C. G.; Maynard, H. D. Eur. Polym. J. 2015, 65, 305.
Corresponding Author (33) Xiao, N.; Liang, H.; Lu, J. Soft Matter 2011, 7, 10834.
*(M.H.S.) E-mail: M.Stenzel@unsw.edu.au. (34) Siebert, J. M.; Baumann, D.; Zeller, A.; Mailänder, V.;
Notes Landfester, K. Macromol. Biosci. 2012, 12, 165.
(35) Couffin, A.; Delcroix, D.; Martín-Vaca, B.; Bourissou, D.;
The authors declare no competing financial interest.
■
Navarro, C. Macromolecules 2013, 46, 4354.
(36) Brady, R. F. Carbohydr. Res. 1970, 15, 35.
ACKNOWLEDGMENTS (37) Scarano, W.; de Souza, P.; Stenzel, M. H. Biomater. Sci. 2015, 3,
The authors would like to acknowledge Dr. Krzysztof P. 163.
Babiuch for the initial help regarding the monomer syntheses (38) Wu, Z.; Stanley, R. R.; Pittman, C. U. J. Org. Chem. 1999, 64,
and preliminary studies. 8386.
■
(39) Ren, L.; Agarwal, S. Macromol. Chem. Phys. 2007, 208, 245.
REFERENCES (40) Agarwal, S.; Ren, L.; Kissel, T.; Bege, N. Macromol. Chem. Phys.
2010, 211, 905.
(1) Ting, S. S.; Chen, G.; Stenzel, M. H. Polym. Chem. 2010, 1, 1392. (41) Zhang, L.; Eisenberg, A. Polym. Adv. Technol. 1998, 9, 677.
(2) David, A.; Kopecková, P.; Kopecek, J.; Rubinstein, A. Pharm. Res. (42) Zhang, L.; Eisenberg, A. J. Am. Chem. Soc. 1996, 118, 3168.
2002, 19, 1114. (43) Legros, C.; De Pauw-Gillet, M.-C.; Tam, K. C.; Taton, D.;
(3) Ponader, D.; Maffre, P.; Aretz, J.; Pussak, D.; Ninnemann, N. M.; Lecommandoux, S. Soft Matter 2015, 11, 3354.
Schmidt, S.; Seeberger, P. H.; Rademacher, C.; Nienhaus, G. U.; (44) Massey, J. A.; Temple, K.; Cao, L.; Rharbi, Y.; Raez, J.; Winnik,
Hartmann, L. J. Am. Chem. Soc. 2014, 136, 2008. M. A.; Manners, I. J. Am. Chem. Soc. 2000, 122, 11577.
(4) Lundquist, J. J.; Toone, E. J. Chem. Rev. 2002, 102, 555. (45) Molev, G.; Lu, Y.; Kim, K. S.; Majdalani, I. C.; Guerin, G.;
(5) Zhao, J.; Babiuch, K.; Lu, H.; Dag, A.; Gottschaldt, M.; Stenzel, Petrov, S.; Walker, G.; Manners, I.; Winnik, M. A. Macromolecules
M. H. Chem. Commun. 2014, 50, 15928. 2014, 47, 2604.
(6) Sprouse, D.; Reineke, T. M. Biomacromolecules 2014, 15, 2616. (46) Hsiao, M.-S.; Yusoff, S. F. M.; Winnik, M. A.; Manners, I.
(7) Thapa, B.; Kumar, P.; Zeng, H.; Narain, R. Biomacromolecules Macromolecules 2014, 47, 2361.
2015, 16, 3008. (47) Kopeček, J. Biomaterials 1984, 5, 19.
(8) Babiuch, K.; Dag, A.; Zhao, J.; Lu, H.; Stenzel, M. H. (48) Liederer, B. M.; Borchardt, R. T. J. Pharm. Sci. 2006, 95, 1177.
Biomacromolecules 2015, 16, 1948. (49) Mathiowitz, E.; Jacob, J. S.; Jong, Y. S.; Carino, G. P.;
(9) Vert, M.; Doi, Y.; Hellwich, K.-H.; Hess, M.; Hodge, P.; Kubisa, Chickering, D. E.; Chaturvedi, P.; Santos, C. A.; Vijayaraghavan, K.;
P.; Rinaudo, M.; Schué, F. Pure Appl. Chem. 2012, 84, 377. Montgomery, S.; Bassett, M. Nature 1997, 386, 410.
(10) Chen, W.; Meng, F.; Cheng, R.; Deng, C.; Feijen, J.; Zhong, Z. J. (50) Duncan, R.; Cable, H.; Lloyd, J.; Rejmanová, P.; Kopecek, J.
Mater. Chem. B 2015, 3, 2308. Makromol. Chem. 1983, 184, 1997.
(11) Xu, N.; Wang, R.; Du, F. S.; Li, Z. C. J. Polym. Sci., Part A: Polym. (51) Burtis, C. A.; Ashwood, E. R. Tietz Fundamentals of Clinical
Chem. 2009, 47, 3583. Chemistry, 4th ed.; Saunders: Philadelphia, PA, 1996; p 803.
(12) Bailey, W.; Chen, P.; Chiao, W.-B.; Endo, T.; Sidney, L.; (52) Gan, Z.; Jim, T. F.; Li, M.; Yuer, Z.; Wang, S.; Wu, C.
Yamamoto, N.; Yamazaki, N.; Yonezawa, K. In Contemporary Topics in Macromolecules 1999, 32, 590.
Polymer Science; Shen, M., Ed.; Springer: US, 1979; p 29. (53) Lam, H.; Gong, X.; Wu, C. J. Phys. Chem. B 2007, 111, 1531.
(13) Agarwal, S. Polym. Chem. 2010, 1, 953. (54) Chawla, J. S.; Amiji, M. M. Int. J. Pharm. 2002, 249, 127.
(14) Delplace, V.; Nicolas, J. Nat. Chem. 2015, 7, 771. (55) Wu, C.; Jim, T.; Gan, Z.; Zhao, Y.; Wang, S. Polymer 2000, 41,
(15) Delplace, V.; Tardy, A.; Harrisson, S.; Mura, S.; Gigmes, D.; 3593.
Guillaneuf, Y.; Nicolas, J. Biomacromolecules 2013, 14, 3769. (56) Zhao, Y.; Hu, T.; Lv, Z.; Wang, S.; Wu, C. J. Polym. Sci., Part B:
(16) Wei, Y.; Connors, E. J.; Jia, X.; Wang, C. J. Polym. Sci., Part A: Polym. Phys. 1999, 37, 3288.
Polym. Chem. 1998, 36, 761. (57) Kim, S.; Shi, Y.; Kim, J. Y.; Park, K.; Cheng, J.-X. Expert Opin.
(17) Delplace, V.; Guégain, E.; Harrisson, S.; Gigmes, D.; Guillaneuf, Drug Delivery 2010, 7, 49.
Y.; Nicolas, J. Chem. Commun. 2015, 51, 12847. (58) Vichai, V.; Kirtikara, K. Nat. Protoc. 2006, 1, 1112.
(18) Wickel, H.; Agarwal, S.; Greiner, A. Macromolecules 2003, 36,
2397.